Highest-materiality recent filing
TransAct appoints Troy Ingianni as CFO effective July 1, 2026 after Campbell withdrawal
Troy Ingianni appointed CFO, Secretary & Treasurer, effective July 1, 2026.
TransAct Q1 sales up 10% to $14.4M, CFO DeMartino to retire June 30, $3M buyback
Q1 net sales $14.4M (+10% YoY), net income $766k ($0.07 EPS), op income $771k, adj EBITDA $1.4M.
TransAct reports Q4 net loss $1.1M, FY net sales +19% to $51.5M; guides 2026 rev $55-57M
Q4 net sales $11.5M (+12% YoY); FY net sales $51.5M (+19% YoY).
TransAct Q3 net sales up 21% to $13.2M; turns profitable with $15k net income
Net sales $13.2M (+21% YoY); net income $15k ($0.00 EPS) vs loss of $551k a year ago.
TransAct Q2 rev $13.8M (+19% YoY); net loss narrows; acquires BOHA! source code for $2.55M
Q2 net sales $13.8M (+19% YoY), net loss $143K ($0.01/sh) vs $319K loss a year ago.
TransAct Q1 net income $19k vs loss of $1.0M a year ago; record 2,350 BOHA! terminals sold
Net sales $13.1M, up 22% YoY and 28% sequentially; FST revenue rose 49% YoY to all-time quarterly high.
TransAct Q4 net loss $8.0M includes $7.3M tax valuation allowance; guides FY2025 sales $47-52M
Q4 net sales $10.2M, down 23% YoY; full-year 2024 sales $43.4M, down 40%.
TransAct Q3 net sales $10.9M (-37% YoY), loss $(0.06)/share; revises FY24 sales guidance to $43-45M
Net sales $10.9M, down 37% vs $17.2M in Q3 2023; net loss $(551K) or $(0.06) per share.
TransAct Q2 net loss $319k on sales $11.6M (-42% YoY); guidance improved
Q2 net sales $11.6M, down 42% YoY but up 9% sequentially from Q1 2024.
Company actively assessing strategic alternatives with Roth Capital Partners LLC as advisor.
TransAct Q1 net sales drop 52% to $10.7M; net loss $1.0M vs profit year ago
Net loss $1.0M ($0.10 loss per diluted share) vs net income $3.1M ($0.31) in Q1 2023.
TransAct Q4 net sales down 26% YoY to $13.3M; net loss $62K vs. $260K profit in Q4 2022
Q4 2023 net loss $62K ($0.01 per diluted share); FY2023 net income $4.7M ($0.47 diluted) vs. FY2022 net loss $5.9M.
Net sales $17.2M (-4% YoY); net income $906k ($0.09/diluted) vs $528k ($0.05) in Q3 2022.
TransAct Q2 net sales $19.9M (+58% YoY); casino sales surge 87%
Net sales $19.9M, up 58% YoY; casino & gaming sales $12.2M (+87%); FST sales $3.9M (+14%).
TransAct Q1 revenue up 130% to $22.3M, net income $3.1M; CEO made permanent
Net sales $22.3M (+130% YoY) driven by casino/gaming $15.8M (+232%) and FST $3.5M (+62%).
TransAct Technologies CEO Bart Shuldman steps down; John Dillon named interim CEO
Shuldman's CEO tenure ended April 4, 2023; separation agreement provides two years base salary ($595,801/yr) and pro-rated bonus ($115,079).
Bart Shuldman stepped down as CEO and director effective April 4, 2023, after 27 years.
TransAct Q4 net sales $18.0M (+61% YoY); casino/gaming sales up 123% to $11.0M
Q4 net income $0.3M ($0.03 EPS) vs net loss $(0.8M) a year ago; adjusted net income also $0.03.
TransAct Q3 net sales $17.9M (+68% YoY); net income $0.5M vs $0.9M year-ago
Net sales $17.9M vs $10.6M YoY; gross margin improved to 45.9% from 40.5%.
TransAct Q2 net sales up 35% to $12.6M; net loss widens to $2.4M from $2.0M
Net sales $12.6M (+35% YoY); gross margin 43.0% vs 36.8%.
TransAct stockholders approve board declassification; directors elected at 2022 annual meeting
Stockholders voted to amend certificate of incorporation to declassify board over three years, effective May 31, 2022.
TransAct Q1 net loss widens to $4.0M; revenue up 17% to $9.7M but margins shrink
Net loss of $(4.0)M or $(0.41)/diluted share vs $(2.2)M loss ($(0.25)) in Q1 2021.
Board expands from 5 to 7 directors; Daniel Friedberg (325 Capital) and Audrey Dunning appointed.
TransAct Q4 2021 net sales $11.1M (+43% YoY), net loss $(0.07)/sh, FST recurring revenue $2.1M
Q4 net sales $11.1M, up 43% from $7.8M in Q4 2020; gross margin improved to 39.7% from 30.6%.
TransAct confirms receipt of director nominations from 325 Capital and Harbert Management
Received nomination notice for two candidates to stand for election to the Board at 2022 Annual Meeting.
TransAct Q3 net sales $10.6M (+46% YoY); net income $0.9M; FST recurring revenue up 28%
Net sales $10.6M, up 46% from $7.3M in Q3 2020.
TransAct Technologies issues 109,875 shares at $14.50 in full exercise of over-allotment option
Issued 109,875 shares at $14.50 per share upon full exercise of underwriters' over-allotment option.
TransAct completes $10.6M public offering of 732,500 shares at $14.50/share
Closed underwritten offering of 732,500 new common shares at $14.50 each, gross proceeds ~$10.6M.
TransAct Q2 net sales up 76% to $9.3M; FST recurring revenue record $2.1M (+214%)
Net sales $9.3M, up 76% YoY from $5.3M; gross margin 35.7% vs 43.3% last year.
On June 26, 2026, Mr. Campbell advised the Board that he would step down as Principal Accounting Officer effective June 30, 2026.
on June 26, 2026, the Board appointed Troy W. Ingianni to serve as the Company’s Chief Financial Officer, Secretary and Treasurer, effective July 1, 2026
Steven A. DeMartino, President, Chief Financial Officer, Secretary and Treasurer of TransAct Technologies Incorporated (the “Company”), will retire from those roles effective June 30, 2026
John M. Dillon, the Company’s Chief Executive Officer, will assume the title of President effective upon Mr. DeMartino’s retirement.
appointed Robert Campbell to succeed Mr. DeMartino as Chief Financial Officer, Secretary and Treasurer of the Company, effective upon Mr. DeMartino’s June 30, 2026 retirement
John Dillon, the Company’s Chief Executive Officer, will assume the title of President of the Company at the Transition Time
Steven A. DeMartino to Retire Effective June 30, 2026
On May 8, 2023, the Board of Directors (the “Board”) of the Company unanimously agreed that John M. Dillon, who was appointed Chief Executive Officer (“CEO”) of the Company on April 4, 2023, will continue in the role indefinitely and is no longer serving on an “interim” basis.
Bart C. Shuldman had stepped down as the Company’s Chief Executive Officer and as a director of the Company, effective immediately
the Board appointed John M. Dillon, a Board member, to serve as interim Chief Executive Officer of the Company, effective as of the Effective Time.
On April 4, 2023, the Board appointed John M. Dillon, a Board member, to serve as interim Chief Executive Officer of the Company, effective as of the Effective Time.
On April 5, 2023, TransAct Technologies Incorporated (the “Company”) announced that on April 4, 2023, Bart C. Shuldman had stepped down as the Company’s Chief Executive Officer and as a director of the Company, effective immediately (the “Effective Time”).
Max materiality 0.85 · Median 0.60 · Most common event earnings